Short title: NK and ILC Developmental Pathways
Introduction
ILC represent an expanding family of innate effector cells that have critical roles in the generation and maintenance of immunity, especially at mucosal surfaces. Natural Killer (NK) cells can be considered as the founding member of the ILC family, having immunological characteristics that include a lymphoid developmental origin, absence of clonally rearranging antigen receptors, and an activation profile that includes T--bet (Tbx21)--regulated prompt cytokine production (IFN--γ) but generally does not result in long--lasting immunological memory. We know much about the molecular determinants that guide NK cell development and generate these potent innate effector cells in both mouse and man (reviewed in [1] [2] [3] ). The second ILC family member identified was the Lymphoid Tissue--inducer (LTi) cell that expresses the retinoic acid receptor--related orphan receptor γt (RORγt) and has a determinant role in lymphoid tissue formation during fetal and adult life. In adult mice, RORγt--expressing LTi cells can also promptly produce IL--17 and IL--22 following activation with cytokines such as IL--1β and IL--23 suggesting that LTi cells have additional roles in immune defense (reviewed in [4] ).
More recently, other IL--22--producing RORγt + ILC that express natural cytotoxicity receptors have been described in mucosal tissues from mice and man (reviewed in [5] ).
Finally, novel ILC subsets that have the capacity to produce high levels of the Th2 cytokines IL--5 and IL--13 were discovered and variably named natural helper cells, nuocytes or innate helper cells (reviewed in [6] ). All of these different ILC subsets have common characteristics of lymphoid morphology, independence from the recombinase machinery, and a common developmental dependence for the transcriptional repressor Id2 and for γc cytokines (reviewed in [7] ). Recently, a standardized nomenclature was proposed for describing these functionally different ILC subsets: group 1 ILC include NK and other ILC that produce IFNγ and are dependent on T--bet for their development and function; group 2 ILC comprise ILC that produce type 2 cytokines (IL--4, IL--5, IL--9 and IL--13) and are dependent on Gata3 and RORα for their development and function; and group 3 ILC subtypes that produce IL--17 and/or IL--22 and depend on RORγt for their development and function (reviewed in [••8] ). This framework clusters cells based primarily on functional characteristics but also on signature transcription factors that drive their cytokine production. Still, functional plasticity is characterized by modifications in cytokine secretion profiles that can result from changes in transcription factor expression. As such, an inter--conversion between different ILC subsets may occur during immune responses or following ILC activation. Nevertheless, this ILC nomenclature may be useful to help understand and define the general principles that guide the development of ILC subsets from hematopoietic precursors.
While these new ILC subsets have generated considerable interest and excitement within the scientific community, remarkable advances in our understanding of the development and functional differentiation of NK cells have as well been recently reported. In this review, we will discuss our current knowledge on the development of NK cells from early hematopoietic precursors in the mouse, focusing on the transcription factors that orchestrate this process and discuss how these developmental pathways may also provide insights in to the developmental biology of other ILC subsets.
A Refined Model for Bone Marrow NK cell Development in the mouse
During hematopoiesis hematopoietic stem cells give rise to progressively more restricted precursor populations that generate lymphoid restricted common lymphoid progenitor (CLP) as well as precursors with restricted myeloid potential (CMP). In the mouse, CLP possess precursor potential for T, B, and NK cell at the single cell level [9] , and can give rise to ILC2 at the population [••10,11] and single cell level (Klein Wolterink and Di Santo, submitted). CLP are lineage marker (Lin --) negative and express of low levels of c--Kit (CD117), Sca1 (Ly6A/E), IL7Rα (CD127) and Flk2/Flt3 (CD135). A decade ago, we reported identification of the earliest murine NK cell committed precursor (NKP) residing within a Lin --population expressing the IL2/15Rβ chain (CD122) [12] . The developmental potential of this population was limited to NK cells, but only gave rise to NK cells in vitro with a frequency of one in ten, indicating that the NKP subset was not functionally homogeneous. The fact that only 10% of phenotypically defined NKP had true NK precursor potential meant that mutations strongly affecting NKP development could go unnoticed, while normal NKP numbers might still be present in mice lacking almost all phenotypically defined NKPs. As such, it was difficult to reach definitive conclusions regarding factors that influence NKP homeostasis. While the identification of NKP was an important advance, the pathway between CLP and NKP was still poorly defined. are equally dependent on Id2 activity for their development [7, 8] . This would place Id2 at an early stage of ILC development, potentially involved in the generation of a common ILC precursor. While earlier analysis of NKP in Id2 --/--mice suggested a normal development of NKP [24] , a further analysis of rNKP as well as pre--NKP/pre--pro NKP cells in these mice should also be performed. This would provide interesting information on the role of Id2 repressor activity in early ILC precursor development.
Thymocyte selection--associated high mobility group box (Tox) is a second example of a TF that predominantly affects ILC but not T and B cell commitment. Tox deficiency ablates NK cell development and in addition, strongly reduces generation of group ILC3, especially LTi cells, resulting in decreased lymph node and Peyer's patch formation [25] . Whether Tox is required for the generation of ILC2 or other ILC3 subsets The TF Tbx21 (encoding T--bet) was initially described as a 'master regulator' of Th1 differentiation and also shown to control IFN--γ production in various T cell subsets.
The initial analysis of NK cell differentiation in T--bet KO mice found several defects [36] , although most appeared related to the homeostasis of mature NK cells that may be related to regulation of receptors for S1P5 [37] . Tbx21 is a member of a larger family of TF that also includes the broadly expressed Eomesodermin [38] . Functional redundancy between T--box TF has been demonstrated in several cell types and T--bet/Eomes are co--expressed in CD8 + T cells where they have overlapping/redundant roles [39, 40] .
Recently, an interesting study of the specific versus redundant role of T--bet and Eomes 
